# Filing Detail

Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001571049-17-003097
Filing Date
2017-03-31
Accepted
2017-03-31 17:18:41
Documents
5
Period of Report
2017-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRELIMINARY PROXY STATEMENT | t1700920-prem14a.htm | PREM14A | 2605163
2 | GRAPHIC | lg_caladrius.jpg | GRAPHIC | 208381
3 | GRAPHIC | sg_mts-securities.jpg | GRAPHIC | 26375
4 | GRAPHIC | t1700920_pc01.jpg | GRAPHIC | 670746
5 | GRAPHIC | t1700920_pc02.jpg | GRAPHIC | 261773
| Complete submission text file | 0001571049-17-003097.txt |  | 4196204

Mailing Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920
Business Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920 908-842-0100
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-33650 | Film No.: 17731391
SIC: 8090 Services-Misc Health & Allied Services, NEC